(NASDAQ:RKLB), LONG BEACH, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) — Rocket Lab Corporation (Nasdaq: RKLB) (“Rocket Lab” or “the Company”), a global leader in launch services and space systems, today announced the clearance of their Systems Integration Review (SIR) and completion of their Photon spacecraft for Eta Space and NASA's LOXSAT mission. LOXSAT is an […]

(NASDAQ:CVRX), MINNEAPOLIS, Oct. 22, 2025 (GLOBE NEWSWIRE) — CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today announced that it plans to release third quarter 2025 financial and operating results after market close on Wednesday, Nov. 5, 2025. The

ODDITY to Announce Third Quarter 2025 Financial Results on November 19, 2025 GlobeNewswire October 22, 2025 NEW YORK, Oct. 22, 2025 (GLOBE NEWSWIRE) — ODDITY Tech Ltd. (“ODDITY”) (NASDAQ: ODD), today announced that it will release its third quarter 2025 financial results after the market close on Wednesday, November 19, 2025, to be followed by

Live Oak Bancshares, Inc. Reports Third Quarter 2025 Results GlobeNewswire October 22, 2025 WILMINGTON, N.C., Oct. 22, 2025 (GLOBE NEWSWIRE) — Live Oak Bancshares, Inc. (NYSE: LOB) (“Live Oak” or “the Company”) today reported third quarter of 2025 net income attributable to common shareholders of $25.6 million, or $0.55 per diluted common share. Live Oak's

TowneBank Reports Third Quarter 2025 Earnings GlobeNewswire October 22, 2025 SUFFOLK, Va., Oct. 22, 2025 (GLOBE NEWSWIRE) — TowneBank (the “Company” or “Towne”) (NASDAQ: TOWN) today reported earnings for the quarter ended September 30, 2025 of $38.98 million, or $0.51 per diluted share, compared to $42.95 million, or $0.57 per diluted share, for the quarter

Vor Bio to Host Webcast on Late-Breaking China Phase 3 Telitacicept Data in Primary Sjogren's Disease GlobeNewswire October 22, 2025 CAMBRIDGE, Mass., Oct. 22, 2025 (GLOBE NEWSWIRE) — Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, announced today that it will host a live webcast to present and discuss

Clover Health to Participate in Upcoming 2025 UBS Global Healthcare Conference GlobeNewswire October 22, 2025 WILMINGTON, Del., Oct. 22, 2025 (GLOBE NEWSWIRE) — Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Chief Financial Officer, Peter Kuipers, will present at the 2025 UBS Global Healthcare Conference on Tuesday,

Rocket Lab Completes Spacecraft for Cryogenic Fueling Mission with Eta Space and NASA GlobeNewswire October 22, 2025 LONG BEACH, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) — Rocket Lab Corporation (Nasdaq: RKLB) (“Rocket Lab” or “the Company”), a global leader in launch services and space systems, today announced the clearance of their Systems Integration Review (SIR)

CVRx to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call on Nov. 5, 2025 GlobeNewswire October 22, 2025 MINNEAPOLIS, Oct. 22, 2025 (GLOBE NEWSWIRE) — CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today announced

ES Bancshares, Inc. Announces Third Quarter 2025 Results; Continues Positive Trend of Net Income Growth GlobeNewswire October 22, 2025 STATEN ISLAND, N.Y., Oct. 22, 2025 (GLOBE NEWSWIRE) — ES Bancshares, Inc. (OTCQX: ESBS) (the “Company”) the holding company for Empire State Bank, (the “Bank”) today reported net income of $637 thousand, or $0.10 per diluted